Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series
APCRI Journal · 2023
DOI: 10.24321/0973.5038.202310 ↗Kurz gefasst
Fachartikel in der Zeitschrift APCRI Journal, 2023. Verfasst von Saramma Abraham.
Abstract (Originalsprache)
Introduction
Rabies is a vaccine preventable zoonotic disease, however, if not prevented in time, it may become 100% fatal. Combining vaccine- immunoglobulin therapy with proper wound care is advised for effective rabies prevention. Equine rabies immunoglobulin is cheaper than human rabies immunoglobulin, but there is an increased chance of hypersensitivity reaction following its administration.
Method
A case series study has been presented in this article consisting of three different presentations of hypersensitivity reactions after the administration of equine rabies immunoglobulin.
Results
Two cases developed an immediate allergic reaction after desensitization. The third case showed a delayed local reaction and did not develop any allergy during the skin test before administering the full dose.
Conclusion
In a poor resource setting like India, skin sensitivity testing may be continued to identify high risk patients, and provide desentization, but still allergic reactions may be anticipated for them.
Zitieren
APA
Abraham, S. (2023). Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series. APCRI Journal. https://doi.org/10.24321/0973.5038.202310
Vancouver
Abraham S. Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series. APCRI Journal. 2023. doi:10.24321/0973.5038.202310
BibTeX
@article{Abraham2023,
author = {Abraham, Saramma},
title = {Allergic Manifestations to Equine Rabies Immunoglobulin: A Case Series},
journal = {APCRI Journal},
year = {2023},
doi = {10.24321/0973.5038.202310}
}
EUVIMED